Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$112.98M
Total Bought:
$17.72M
Total Sold:
$26.43M
Net Transaction:
-$8.70M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Aclaris Therapeutics, Inc.(ACRS)14,250,00014,250,0000$27.07M$42.89M37.97%+$15.82M
Atea Pharmaceuticals, Inc.(AVIR)7,473,9637,490,000+16,037$21.67M$26.74M23.67%+$5.06M
Oramed Pharmaceuticals Inc.(ORMP)3,167,2313,167,2310$8.36M$9.03M7.99%+$665.1K
Instil Bio, Inc.(TIL)645,600645,6000$11.53M$7.10M6.29%-$4.43M
PMV Pharmaceuticals, Inc.(PMVP)5,292,0005,292,0000$7.41M$6.62M5.86%-$793.8K
CarMax, Inc.(KMX)0155,000+155,000$0$5.99M5.30%+$5.99M
Kezar Life Sciences Inc
COM NEW
720,787720,7870$2.81M$4.53M4.01%+$1.72M
Target Corporation(TGT)10,00037,500+27,500$897.0K$3.67M3.24%+$2.77M
Outset Medical, Inc.(OM)0543,180+543,180$0$2.02M1.78%+$2.02M
Pliant Therapeutics, Inc.(PLRX)01,546,137+1,546,137$0$1.89M1.67%+$1.89M
ImageneBio, Inc.(IMA)182,509177,026-5,483$1.49M$1.22M1.08%-$266.0K
Connect Biopharma Holdings LimitedSHS(CNTB)1,267,500408,887-858,613$1.91M$1.15M1.02%-$760.9K
Lisata Therapeutics, Inc.(LSTA)109,84173,348-36,493$287.8K$136.4K0.12%-$151.4K
Mural Oncology Pub Ltd Co57,5000-57,500$119.0K$0—-$119.0K
Lava Therapeutics NvSHS1,970,6100-1,970,610$3.07M$0—-$3.07M
Adverum Biotechnologies Inc3,057,5260-3,057,526$13.85M$0—-$13.85M
Alumis Inc1,210,4150-1,210,415$4.83M$0—-$4.83M
Arvinas, Inc.(ARVN)50,0000-50,000$426.0K$0—-$426.0K
Astrotech Corp220,4100-220,410$1.08M$0—-$1.08M
LeonaBio, Inc.(LONA)323,0660-323,066$1.34M$0—-$1.34M
Third Harmonic Bio Inc3,824,4170-3,824,417$0$0—$0
Vistagen Therapeutics, Inc.(VTGN)150,0000-150,000$532.5K$0—-$532.5K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q4 2025 | TickerTrail